Article
Computationally designed mRNA-launched protein nanoparticle vaccines
2024-07-23
Abstract excerpt
Both protein nanoparticle and mRNA vaccines were clinically de-risked during the COVID-19 pandemic. These vaccine modalities have complementary strengths: antigen display on protein nanoparticles can enhance the magnitude, quality, and durability of antibody responses, while mRNA vaccines can be rapidly manufactured and elicit antigen-specific CD4 and CD8 T cells. Here we leverage a computationally designed icosah...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- cbed9dd0-5fa8-5c13-9871-e05536ce3856
- DOI
- 10.1101/2024.07.22.604655
